Related Experiment Video
Updated: Aug 20, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Fracture rates in Parkinson's disease compared with age- and gender-matched controls: a retrospective cohort study
Richard W Genever1, Thomas W Downes, Pippa Medcalf
1Sheffield Teaching Hospitals NHS Foundation Trust, Northern General Hospital, Herries Road, Sheffield S5 7AU, UK. richard.genever@sth.nhs.uk
Introduction:
Patients with Parkinson's disease (PD) are not routinely prescribed bone-protecting medication despite the fact that they are known to be at risk of falling. We investigated whether subjects with PD were more at risk of fractures than other patient groups in order to establish whether preventative measures should be targeted on those who have been diagnosed with PD.
Methods:
We performed a retrospective cohort study, reviewing the records of PD patients compared with age- and gender matched patients attending medical clinics. Power analysis indicated the need for 194 in each group for a 95% confidence level. Our study comprised 200 PD patients and 200 controls. All limb and vertebral fractures before the date of diagnosis, or control, were recorded.
Results:
52% of patients in each group were female. The mean age of the PD patients was 75.6 years (43.7-96.0) and that of controls 75.2 years (43.9-95.9). The mean interval from diagnosis was 5.46 years, providing 1092 person-years of follow-up in both groups. Fractures were significantly more common in the PD group than the control group (PD 15%, controls 7.5%; p = 0.007). The commonest site of fracture was femur in PD patients (11 of 38 fractures) and forearm in the control group (5 of 16 fractures).
Conclusion:
The risk of fracture is significantly increased in PD relative to patients with other medical conditions. Hip fractures are commonly fatal in older people and partly preventable. Prospective studies of intervention to prevent fractures in PD are required.
Related Concept Videos
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...